H
Harvest
Tax-loss replacement research
SRPT
Sarepta Therapeutics
Health Care›Biotechnology›Biotechnology
28 stocks · 12 ETFs
data as of Oct 8, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for SRPT

Among the 28 Biotechnology peers screened, VIR (Vir Biotechnology, Inc.) has tracked SRPT most closely over the past year, with a return correlation of 0.42. The strongest fund stand-in is XBI (SPDR S&P Biotech ETF) at 0.53 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
VIRVir Biotechnology, Inc.Biotechnology0.420.240.230.14
ARWRArrowhead PharmaceuticalsBiotechnology0.360.330.340.29
RCUSArcus Biosciences, Inc.Biotechnology0.330.250.250.22
XNCRXencor IncBiotechnology0.320.290.300.31
BMRNBioMarin PharmaceuticalBiotechnology0.310.240.280.32
ALNYAlnylam PharmaceuticalsBiotechnology0.300.220.230.27
VRTXVertex PharmaceuticalsBiotechnology0.300.230.240.27
NBIXNeurocrine BiosciencesBiotechnology0.280.170.210.26
EXELExelixisBiotechnology0.280.150.190.26
FTREFortreaBiotechnology0.280.230.22—
REGNRegeneron PharmaceuticalsBiotechnology0.270.240.230.26
AMGNAmgen Inc.Biotechnology0.240.200.200.23
INCYIncyteBiotechnology0.240.190.200.24
TGTXTG Therapeutics, Inc.Biotechnology0.220.180.190.21
BIIBBiogen Inc.Biotechnology0.220.210.210.22
MRNAModerna Inc.Biotechnology0.210.180.180.15
CYTKCytokineticsBiotechnology0.210.140.200.23
ROIVRoivant SciencesBiotechnology0.200.210.17—
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.190.160.210.25
VCELVericelBiotechnology0.190.230.230.19
RGENRepligenBiotechnology0.190.180.210.23
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.180.050.110.10
KRYSKrystal BiotechBiotechnology0.180.220.180.19
PTGXProtagonist Therapeutics, Inc.Biotechnology0.170.140.160.11
GILDGilead SciencesBiotechnology0.170.160.160.19
UTHRUnited TherapeuticsBiotechnology0.150.120.130.19
ADMAADMA Biologics, Inc.Biotechnology0.120.140.170.15
HALOHalozymeBiotechnology0.120.100.150.23
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.530.430.430.47
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.490.410.420.45
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.410.310.340.38
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.380.280.320.36
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.310.250.260.33
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.300.270.280.33
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.290.260.280.33
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.270.250.260.32
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.240.200.220.28
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.220.220.230.29
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.160.170.210.27
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.120.140.170.24
NEXT STEPS

Harvesting a loss in SRPT?

RELATED

Replacement research for SRPT's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.